<DOC>
	<DOCNO>NCT00644332</DOCNO>
	<brief_summary>According American Heart Association ( AHA ) 2011 update heart disease stroke statistic , 9 million adult patient United States ( US ) angina . This update also note study 4 national cross-sectional health examination study find , among Americans 40 74 year age , age-adjusted prevalence angina high among woman men . Per ACC/AHA guideline , goal antianginal therapy complete near complete elimination anginal chest pain return normal activity functional capacity . However , evaluate angina response antianginal therapy often straightforward . This particularly true female patient angina . Because angina response antianginal therapy may differ men woman , instrument design specifically address symptomatology woman angina could enhance understanding characterization angina response therapy population . The current study evaluate validity , reliability , responsiveness newly develop Women 's Ischemia Symptom Questionnaire ( WISQ ) base change angina symptomatology female angina population treat ranolazine , compare widely use Seattle Angina Questionnaire ( SAQ ) .</brief_summary>
	<brief_title>An Open-label , Multi-center Study Evaluating Validity , Reliability , Responsiveness New Female-specific Angina Questionnaire Women With Chronic Angina Treated With Ranolazine Extended-release Tablets ( CVT 3041 )</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>At least 3 month document history stable angina angina equivalent relieve rest and/or sublingual NTG Taking antianginal therapy betablockers , and/or dihydropyridine calcium antagonist , and/or longacting nitrate least 4 week Mean angina frequency â‰¥ 2 attack per week Documented clinical evidence ischemia Clinically significant hepatic impairment Uncontrolled clinically significant cardiac arrhythmia history ventricular fibrillation , torsades de point , lifethreatening ventricular arrhythmia associate acute coronary syndrome Treatment strong cytochrome P450 inhibitor include ketoconazole , itraconazole , clarithromycin , nefazodone , nelfinavir , ritonavir , indinavir , saquinavir Prior treatment ranolazine Endstage renal disease require dialysis Myocardial infarction unstable angina</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>